ANRS Emerging infectious diseases
9:30 a.m.
Welcome coffee
10:00 a.m.
Introduction
• Didier LEPELLETIER, Director General of Health
• Jean-Luc MOULLET, Director General of Research and Innovation
• Yazdan YAZDANPANAH, Director of ANRS Emerging infectious diseases
10:30 a.m.
Keynote
- M. Aurélien JOBARD, Chef de projet OSIRIS – Institut national du cancer
- Dre Christine LE BIHAN, Responsable du département données et évaluation en santé – Institut national du cancer
- M. Aurélien JOBARD, Chef de projet OSIRIS – Institut national du cancer
11:30 a.m.
Session 1 - New surveillance and diagnostic methods
• Cheikh Tidiane DIAGNE, Pasteur Institute, Dakar, Senegal
• Antoine GESSAIN, Pasteur Institute, Paris
1:00 p.m.
Lunch break
2:00 p.m.
Session 1 (continued) - New surveillance and diagnostic methods
• Mircea SOFONEA, PCCEI, University of Montpellier, France
3:30 p.m.
Coffee break
4:00 p.m.
Round table 1 - Promoting academic research: opportunities and support
Moderator : Paul DE BREM
• Joel LELIEVRE, GSK / Tres Cantos Open Lab Foundation, Spain (To be confirmed)
• Alban DHANANI, ANSM, Saint-Denis, France (To be confirmed)
• Jean-Philippe HERBEUVAL, University of Paris Cité (To be confirmed)
• Rosalie MAURISSE, BPI France, Paris, France
• Pascale AUGE, Inserm Transfert, Paris, France
5:15 p.m.
Closing Day
• Didier SAMUEL, Chief Executive Officer of Inserm, Paris, France
5:30 p.m.
Cocktail reception
8:15 a.m.
Welcome coffee
9:00 a.m.
Opening Day
• Charles-Edouard ESCURAT, Director General of French Health Innovation Agency
• Isabelle RICHARD, Chair of the ANRS MIE advisory board, Director of the École des hautes études en santé publique (School of Advanced Studies in Public Health)
9:30 a.m.
Keynote
• Glenda GRAY, University of the Witwatersrand, Johannesburg, South Africa
10:00 a.m.
Session 2 - Vaccinology in the era of new technologies
• Emmanuele ANDREANO, National Centre for Pandemic Preparedness, Siena, Italy
• Saranya SRIDHAR, Sanofi Vaccines, London, UK
• Isabelle DIMIER-POISSON, University of Tours / INRAE, France
• Maria-Carla SALEH, Pasteur Institute, Paris, France (To be confirmed)
• Young scientist: Raul Yusef SANCHEZ DAVID, Blizard Institute, Queen Mary University of London, UK
12:15 p.m.
Lunch break
1:30 p.m.
Session 3 - Innovative therapeutic approaches
• Bruno PITARD, University of Nantes, CNRS / Inserm, France (To be confirmed)
• Dusan BOGUNOVIC, Columbia University (To be confirmed)
3:00 p.m.
Coffee break
3:45 p.m.
Session 3 (continued) - Innovative therapeutic approaches
• Edwin ROSADO-OLIVIERI, New York University, USA
• Young scientist: Adeline CÉZARD, CEPR, Tours, France
4:45 p.m.
Round table 2 - How can we ensure global access to new treatments? Conversations about HIV
Modérateur : Paul DE BREM
5:55 p.m.
Closing Day & end of the Scientific Days
• Anne-Claire AMPROU, Ambassador for Global Health
• Yazdan YAZDANPANAH, Director of ANRS Emerging infectious diseases